Cargando…
Author Correction: AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
Autores principales: | Wang, Ching-Shuen, Maruyama, Christina L., Easley, Justin T., Trump, Bryan G., Baker, Olga J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191453/ https://www.ncbi.nlm.nih.gov/pubmed/30327486 http://dx.doi.org/10.1038/s41598-018-33005-w |
Ejemplares similares
-
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
por: Wang, Ching-Shuen, et al.
Publicado: (2017) -
Genome-wide end-sequenced BAC resources for the NOD/MrkTac(☆) and NOD/ShiLtJ(☆☆) mouse genomes
por: Steward, Charles A., et al.
Publicado: (2010) -
Metabolic abnormalities exacerbate Sjögren’s syndrome by and is associated with increased the population of interleukin–17–producing cells in NOD/ShiLtJ mice
por: Hwang, Sun-Hee, et al.
Publicado: (2020) -
Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren's-Like NOD/ShiLtJ Mice
por: Hu, Peng, et al.
Publicado: (2021) -
AT‐RvD1 combined with DEX is highly effective in treating TNF‐α‐mediated disruption of the salivary gland epithelium
por: Easley, Justin T., et al.
Publicado: (2016)